baxdela

Developed by Melinta Therapeutics, BAXDELA is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections. These marketing pieces were created to educate sales reps and health care professionals on this new and innovative drug, which launched in early 2018.

packaging

website

sales rep detailer

0003_Baxdela_Detailer_1.jpg
0006_Baxdela_Detailer_4.jpg
0005_Baxdela_Detailer_3.jpg
0007_Baxdela_Detailer_5.jpg

moa video

conference booth

0003_Baxdela_Booth_1.jpg
0005_Baxedla_Booth_2.jpg
0004_Baxdela_Booth_3.jpg
0006_Baxdela_Booth_4.jpg

edutainment game